Skip to main content

Advertisement

SpringerLink
Log in

Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Staging laparoscopy (SL) with peritoneal lavage is usually performed on a separate day from the planned resection and is recommended in patients with gastric adenocarcinoma as it can identify radiographically occult metastases and malignant cytology, thus altering prognosis and treatment. SL can be done on the same day as planned resection (SLSR) or with delayed resection (SLDR). The purpose of this study was to determine utilization of SL and factors associated with SLSR and SLDR, among patients diagnosed with gastric adenocarcinoma.

Methods

SEER-Medicare linked data were used to identify patients diagnosed with gastric adenocarcinoma from 2004 through 2013. SL were defined as a laparoscopy that occurred up to 3 months postdiagnosis. Multivariate logistic regression was used to identify factors associated with the utilization of SLSR and SLDR.

Results

Of the 5610 patients with gastric adenocarcinoma who underwent a surgical procedure, 733 (13%) had a SL. Utilization of SL increased annually from 6.4% to 22.2% (p < 0.01). Receipt of SL was associated with patient demographics, tumor location, and treatment at a National Cancer Institute (NCI) Designated Cancer Center (CC). Of the 733 patients who underwent SL, 475 (65%) received further surgical procedures; 367 (77%) underwent SLSR, while 108 patients (23%) underwent SLDR. Compared with SLSR, SLDR was more common among patients who were younger, treated at an NCI-Designated CC and had proximal tumors.

Conclusions

SL for optimal preoperative staging remains underutilized in the management of gastric adenocarcinoma. Expanded use of laparoscopy as a distinct procedure could minimize unnecessary interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    Article  Google Scholar 

  2. Badgwell B, et al. Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery. J Surg Oncol. 2015;111(7):875–81.

    Article  Google Scholar 

  3. Ikoma N, et al. Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol. 2016;23(13):4332–7.

    Article  Google Scholar 

  4. Mezhir JJ, et al. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010;17(12):3173–80.

    Article  Google Scholar 

  5. Bentrem D, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12(5):347–53.

    Article  Google Scholar 

  6. Sarela AI, et al. Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg. 2006;191(1):134–8.

    Article  Google Scholar 

  7. Karanicolas PJ, et al. Staging laparoscopy in the management of gastric cancer: a population-based analysis. J Am Coll Surg. 2011;213(5):644-51, e1.

  8. Snyder RA, et al. Trends in the use of evidence-based therapy for resectable gastric cancer. J Surg Oncol. 2014;110(3):285–90.

    Article  Google Scholar 

  9. SEER. Available at: http://seer.cancer.gov/registries/terms.html.

  10. National Cancer Institute. NCI-Designated Cancer Centers. Available at: https://www.cancer.gov/research/nci-role/cancer-centers. Accessed 15 Nov 2017.

  11. Klabunde CN, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67.

    Article  CAS  Google Scholar 

  12. NCCN. NCCN clinical practice guidelines in oncology, gastric cancer. 2019.

  13. Nassour I, et al. The yield of staging laparoscopy in gastric cancer is affected by racial and ethnic differences in disease presentation. Ann Surg Oncol. 2017;24(7):1787–94.

    Article  Google Scholar 

  14. Washington KJA. 7th Edition of the AJCC Cancer Staging Manual: stomach. 2010;17(12):3077–9.

  15. Abdalla EK, Pisters PW. Staging and preoperative evaluation of upper gastrointestinal malignancies. Semin Oncol. 2004;31(4):513–29.

    Article  Google Scholar 

  16. Reid-Lombardo KM, et al. Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from theNational Cancer Data Base. J Gastrointest Surg. 2007;11(4):410–9; discussion 419–20.

  17. Burke EC, et al. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997;225(3):262–7.

    Article  CAS  Google Scholar 

  18. Son SY, et al. Rapid staining using the shorr method for intraoperative peritoneal washing cytology in advanced gastric cancer: a pilot study from a single institution. J Gastric Cancer. 2019;19(2):173–82.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Eric M. Groh and Shreya Gupta have contributed equally to this work.

Authors and Affiliations

  1. Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Eric M. Groh MD, Shreya Gupta MD, Zachary J. Brown DO, Lauren A. Gamble MD, Jonathan M. Hernandez MD & Jeremy L. Davis MD

  2. Healthcare Assessment Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Lindsey Enewold PhD

Authors
  1. Eric M. Groh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shreya Gupta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zachary J. Brown DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lindsey Enewold PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lauren A. Gamble MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jeremy L. Davis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study conception and design: EMG, ZJB, LE, JMH, JLD; Acquisition of data: EMG, ZJB, LE, SG; Analysis and interpretation of data: EMG, ZJB, LE, SG, JMH, JLD; Drafting of manuscript: EMG, ZJB, LE, SG, JMH, JLD; Critical revisions: EMG, ZJB, LE, SG, LG, JMH, JLD.

Corresponding author

Correspondence to Jeremy L. Davis MD.

Ethics declarations

Disclosure

The authors declare they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Groh, E.M., Gupta, S., Brown, Z.J. et al. Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma. Ann Surg Oncol 27, 1473–1479 (2020). https://doi.org/10.1245/s10434-019-08077-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-08077-1

Search

Navigation